Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Fixed Capital/Sales

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.350.340.310.270.24

What is the latest Fixed Capital/Sales ratio of AUROBINDO PHARMA ?

The latest Fixed Capital/Sales ratio of AUROBINDO PHARMA is 0.35 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.35
Mar20230.34
Mar20220.31
Mar20210.27
Mar20200.24

How is Fixed Capital/Sales of AUROBINDO PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.35
2.94
Mar2023 0.34
9.68
Mar2022 0.31
14.81
Mar2021 0.27
12.50
Mar2020 0.24 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Fixed Capital/Sales ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹63,667.3 Cr -4.2% -7.8% -12.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹399,249.0 Cr -1.3% -3.3% 8.3% Stock Analytics
DIVIS LABORATORIES ₹174,940.0 Cr -1.5% 0.8% 42.3% Stock Analytics
CIPLA ₹121,197.0 Cr -1.7% 2.3% -5.8% Stock Analytics
DR REDDYS LABORATORIES ₹110,618.0 Cr -1.6% 8.4% 10.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,250.0 Cr -3.3% -1.4% 9.8% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-4.2%

-7.8%

-12.7%

SENSEX

1.6%

1%

7%


You may also like the below Video Courses